Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

Completed · Not applicable

Conditions studied: Methicillin-resistant Staphylococcus Aureus

In brief

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

Key facts

Study ID
NCT01209234
Run by
University of California, Irvine
People needed
2140
Starts
2011-01-01
Expected to finish
2019-01-01
Last updated by the study team
2025-11-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.